Boston Scientific Corp BSX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Boston Scientific Restores Key Operations After Cyberattack
-
Boston Scientific Won't Meet Guidance Due to Cyberattack
-
Boston Scientific Working to Restore Shipments After Cyberattack
-
Boston Scientific Says Cyberattack Disrupting Global Operations — Update
-
Boston Scientific Says Cyberattack Disrupting Global Operations
-
Boston Scientific Logs Higher 2Q, Cuts Outlook Ahead of Restructuring
-
Boston Scientific to Cut Staff in Global Restructuring Program
-
Boston Scientific Down Over 10%, On Track for Lowest Close Since November 2023 — Data Talk
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- CHF 34.97 / CHF 35.20
- Shares Outstanding
- 1.45B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 13.73
- Price/Sales
- 3.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 59,000
- Website
- https://www.bostonscientific.com
Competitors
Valuation
|
Metric
|
BSX
|
MDT
|
ABT
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.73 | 15.63 | 18.93 |
Price/Book Value | 2.51 | 2.25 | 3.37 |
Price/Sales | 3.13 | 3.03 | 3.73 |
Price/Cash Flow | 12.70 | 12.70 | 15.91 |
Price/Earnings
BSX
MDT
ABT
Financial Strength
|
Metric
|
BSX
|
MDT
|
ABT
|
|---|---|---|---|
Quick Ratio | 0.56 | 1.29 | 0.97 |
Current Ratio | 1.24 | 2.07 | 1.38 |
Interest Coverage | 11.56 | 10.12 | 10.40 |
Quick Ratio
BSX
MDT
ABT
Profitability
|
Metric
|
BSX
|
MDT
|
ABT
|
|---|---|---|---|
Return on Assets (Normalized) | 11.01% | 8.31% | 9.71% |
Return on Equity (Normalized) | 19.82% | 15.59% | 17.95% |
Return on Invested Capital (Normalized) | 14.09% | 10.57% | 13.03% |
Return on Assets
BSX
MDT
ABT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|%R?Jx!H | LOCK|!!hY! | $172B | |||
| Medtronic PLC
MDT
| LOCK|zKL#v$ | LOCK|bz>w | $113B | |||
| Stryker Corp
SYK
| LOCK|WjCtY#d$ | LOCK|<j^ | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|cJ^PNk | LOCK|S&zr | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|dn$!Gc$ | LOCK|V^P&q | $49B | |||
| DexCom Inc
DXCM
| LOCK|$#&TT?w | LOCK|Hs@YJ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|VyfB^$ | LOCK|&F | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|YG | LOCK|kLY | $24B | |||
| Steris PLC
STE
| LOCK|x#Mh$V | LOCK|>WZ# | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|>!pyh%& | LOCK|&YG | $17B |
United States